Abstract
Background: Circadian dysfunction is involved in the pathophysiology of bipolar disorders (BD), and circadian-based interventions are gaining recognition in their management. Moreover, basic and epidemiologic research has generated findings inspiring circadian-informed self- and clinician-management strategies. Despite these gains, many Clinical Practice Guidelines and clinical training programs have not incorporated this evidence in their recommendations and curricula.
Aims: This International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force position paper reports a Delphi study-based international consensus statement on what is essential for mental health clinicians to know about the chronobiology and chronotherapy of BD.
Methods: An initial pool of statements was derived via review of academic and grey literatures. Statements were rated on a 5-point scale (essential; important; don't know/depends; unimportant; should not be included). Consensus was reached when statements were rated as essential or important by ≥80% of experts. Two young persons with lived experience of BD gave feedback on acceptability.
Results: Thirty experts from 15 countries in Europe, North and South America, and the Asia Pacific participated (mean age 55.3 years [SD=11.8]; 40% female; 83% psychiatrists; mean clinical and research experience of 26 [SD=10.8] and 22 years [SD=12.6], respectively). Eight-hundred-and-forty-seven ratings occurred across 12 core constructs and three rounds; 470 statements were discarded after one round and 35 were discarded after rerating. Consensus was reached on 342 statements spanning four themes: basic circadian science; circadian health and disruption; chronobiology of BD; and six chronotherapies (e.g., key protocols, outcomes, side effects, risks/contraindications).
Conclusions: This position paper summarises an international consensus statement on the essential information about the chronobiology and chronotherapy of BD that is intended to help clinicians optimise their management of individuals with BD. This knowledge is available online (https://osf.io/agk9y ) and its dissemination is expected to enhance the training and efficacy of clinicians globally.